A study on myeloma found that CXCL12, a key molecule involved in CXCR4-dependent cell retention in bone marrow, was upregulated in circulating plasma cells and potentially induced myeloma cells’ intravasation [31]. Here, CXCR4 is linked to plasma cell myeloma.